GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hangzhou Alltest Biotech Co 688606.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

45.42

-1.07%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥911.3m

FY2016FY2025

Net income

CN¥218.3m

FY2016FY2025

Free cash flow

−CN¥12.5m

FY2016FY2025

Shareholders' equity

CN¥3.95bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥911.3mCN¥866.6mCN¥754.7mCN¥3.39bnCN¥1.87bnCN¥1.14bnCN¥241.3mCN¥184.2mCN¥129.7mCN¥75.7m
Research and developmentCN¥109.3mCN¥95.8mCN¥121.2mCN¥207.3mCN¥95.5mCN¥55.1mCN¥35.9mCN¥30.9mCN¥25.9mCN¥20.1m
Operating incomeCN¥249.7mCN¥345.5mCN¥211.6mCN¥1.39bnCN¥896.7mCN¥792.7mCN¥88.1mCN¥62.5mCN¥37.8mCN¥17.5m
Net incomeCN¥218.3mCN¥302.5mCN¥180.6mCN¥1.18bnCN¥765.7mCN¥679.2mCN¥78.4mCN¥56.4mCN¥34.2mCN¥15.2m
Diluted earnings per share2.753.842.2914.9710.1511.371.930.710.430.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥4.24bnCN¥4.19bnCN¥4.12bnCN¥4.70bnCN¥4.01bnCN¥1.15bnCN¥332.5mCN¥254.6mCN¥190.6mCN¥59.7m
Cash and short-term investments—CN¥2.58bnCN¥2.79bnCN¥3.81bnCN¥2.96bnCN¥700.6mCN¥125.3mCN¥11.9mCN¥43.3mCN¥7.9m
Total liabilitiesCN¥296.1mCN¥302.6mCN¥284.5mCN¥528.8mCN¥734.7mCN¥178.4mCN¥39.3mCN¥39.5mCN¥52.0mCN¥32.4m
Debt—CN¥1.8mCN¥23.9mCN¥21.8mCN¥37.4mCN¥4.4m————
Shareholders' equityCN¥3.95bnCN¥3.88bnCN¥3.83bnCN¥4.17bnCN¥3.27bnCN¥972.7mCN¥293.2mCN¥215.1mCN¥138.6mCN¥27.2m
Shares outstanding79m79m79m79m75m60m41m79m79m79m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥206.6mCN¥329.5mCN¥24.8mCN¥1.36bnCN¥923.9mCN¥622.7mCN¥91.5mCN¥18.6mCN¥20.0mCN¥6.7m
Capital spending−CN¥219.1m−CN¥220.7m−CN¥533.5m−CN¥270.2m−CN¥140.1m−CN¥37.1m−CN¥15.1m−CN¥34.7m−CN¥52.1m−CN¥2.1m
Free cash flow−CN¥12.5mCN¥108.9m−CN¥508.7mCN¥1.09bnCN¥783.8mCN¥585.6mCN¥76.4m−CN¥16.1m−CN¥32.1mCN¥4.6m
Dividends paid−CN¥195.1m−CN¥232.7m−CN¥528.7m−CN¥215.6m−CN¥107.8m—————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥196.8mCN¥195.4mCN¥278.2mCN¥203.2mCN¥221.4mCN¥208.5mCN¥248.6mCN¥221.5m
Operating incomeCN¥36.0mCN¥33.5mCN¥30.9mCN¥66.2mCN¥88.0mCN¥64.6mCN¥118.7mCN¥84.7m
Net incomeCN¥31.5mCN¥19.4mCN¥28.5mCN¥57.8mCN¥70.8mCN¥61.2mCN¥104.9mCN¥73.6m
Diluted earnings per share0.400.240.360.730.890.771.330.94
Cash from operations———CN¥55.0mCN¥50.0mCN¥11.0mCN¥137.0mCN¥89.0m
Capital spending−CN¥20.0m−CN¥22.0m−CN¥60.0m−CN¥38.0m−CN¥36.0m−CN¥83.0m−CN¥43.0m−CN¥51.0m
Free cash flow———CN¥17.0mCN¥14.0m−CN¥72.0mCN¥94.0mCN¥38.0m
Total assetsCN¥4.00bnCN¥4.11bnCN¥4.24bnCN¥4.24bnCN¥4.15bnCN¥4.20bnCN¥4.19bnCN¥4.16bn
Cash and short-term investments———CN¥2.46bnCN¥2.46bnCN¥2.55bnCN¥2.58bnCN¥2.66bn
Debt———CN¥289,510———CN¥3.9m
Shareholders' equityCN¥3.76bnCN¥3.88bnCN¥3.95bnCN¥3.90bnCN¥3.91bnCN¥3.95bnCN¥3.88bnCN¥3.88bn

Financial ratios

Data as of 15 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin27.3%40.3%26.5%40.9%47.9%69.8%
Net margin24.0%34.9%23.9%35.0%40.9%59.8%
Return on equity5.5%7.8%4.7%28.4%23.4%69.8%
Return on assets5.1%7.2%4.4%25.2%19.1%59.0%
Free cash flow yield11.5%14.9%15.2%44.0%30.2%23.6%
Revenue growth5.2%14.8%-77.7%80.9%65.0%370.5%
Earnings growth-27.8%67.5%-84.8%54.8%12.7%766.1%
Current ratio9.88x9.91x11.53x8.20x5.14x5.67x
Debt to equity——0.00x0.00x0.01x0.00x
Equity ratio93.0%92.8%93.0%88.7%81.7%84.5%
Interest coverage888.50x184.82x69.38x373.96x465.24x938.08x
R&D as a share of sales12.0%11.1%16.1%6.1%5.1%4.9%
Buybacks as a share of market value-0.6%0.0%0.5%-5.0%-26.3%-47.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-35.5%-4.3%—
Operating income-43.6%-20.6%—
Net income-43.1%-20.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings23.216.529.94.78.2
Price to sales5.65.87.21.63.4

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 1 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021
Paid in the year1.002.503.006.7572.7031.351
  • 1.48-for-1 split · 9 Jun 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.